Constitutive activation of the JAK-STAT pathway is frequent in cancer and contributes to oncogenesis. Here, we took advantage of the Ba/F3 cell line, a murine proB cell line dependent on IL-3 for growth, to analyse mechanisms of constitutive STAT activation in vitro. Cytokineindependent and tumorigenic Ba/F3 cell lines were derived from a two-step selection process. Cells transfected with a defective IL-9 receptor acquire IL-9 responsiveness during a first step of selection, and progress after a second selection step to autonomously growing tumorigenic cells. Microarray analysis pointed to JAK1 overexpression as a key genetic event in this transformation. Overexpression of JAK1 not only increased the sensitivity to IL-9 but also allowed a second selection step toward cytokine-independent growth with constitutive STAT activation. This progression was dependent on a functional FERM and kinase JAK1 domain. Similar results were observed after JAK2, JAK3 and TYK2 overexpression. All autonomous cell lines showed an activation of STAT5, ERK1-2 and AKT but only TYK2-overexpressing cell lines showed a constitutive activation of STAT3. Thus, JAK overexpression can be considered as one of the oncogenic events leading to the constitutive activation of the JAK-STAT pathway.
Introduction
The JAK-STAT pathway is responsible for signal transduction for a large number of cytokines. STATs (signal transducers and activators of transcription) are a family of seven proteins: STAT1, 2, 3, 4, 5a, 5b and 6. JAKs (Janus kinases) represent a family of four nonreceptor tyrosine kinases, JAK1, JAK2, JAK3 and TYK2 (Kisseleva et al., 2002) . These kinases are associated to cytokine receptors and are activated upon ligand binding. Activated JAKs phosphorylate STATs that dimerize and migrate to the nucleus to regulate the transcription of target genes. Constitutive activation of the JAK-STAT pathway is frequently associated to cancer. Persistent STAT3 phosphorylation is described in solid tumors, while STAT5 activation is essentially found in myeloid and lymphoid malignancies (Bromberg, 2002) . Constitutive STAT activation is typically dependent upon the dysregulation of tyrosine kinases such as Src, v-Abl, BCR-Abl and NPM-Alk (Bowman et al., 2000) . The Tel-JAK2 fusion protein found in acute lymphoblastic leukemias (ALL) with the t(9;12) translocation leads to the constitutive activation of JAK2 and STAT5 (Lacronique et al., 1997) . Recently, an activating mutation in JAK2 (V617F) was found in the majority of patients with polycythemia vera and a significant proportion of patients with other myeloproliferative disorders such as essential thrombocythemia and idiopathic myelofibrosis (Baxter et al., 2005; James et al., 2005; Kralovics et al., 2005; Levine et al., 2005) . When JAK2 V617F was transfected into factor-dependent cells, these cells became hypersensitive to cytokines and rapidly acquired cytokine independence, with constitutive activation of STAT5, the ERK/MAP kinase and the PI3/ AKT pathways. JAK2 V617F homologous mutations in JAK1 and TYK2 also lead to constitutively active kinases .
IL-9 is a multifunctional TH2 cytokine implicated in asthma (Renauld and Van Snick, 2003) . Its activities are mediated by a specific receptor chain that forms a heterodimeric receptor with the gc common chain also involved in IL-2, -4, -7, -15 and -21 signaling. The IL-9 receptor and gc associate with JAK1 and JAK3, respectively, and trigger the STAT1, 3, 5, IRS and Ras-MAPK pathways (Knoops and Renauld, 2004) . Beside the role of IL-9 during immune responses, its growth factor and anti-apoptotic activities on transformed cells suggest a potential role in tumorigenesis. Indeed, IL-9 overexpression induced thymic lymphomas in mice (Renauld et al., 1994) , and IL-9 production is associated with Hodgkin's lymphoma (Merz et al., 1991; Fischer et al., 2003) and HTLV-I transformed T cells (Kelleher et al., 1991) in humans. Moreover, in vitro, dysregulation of the IL-9 response is associated with autonomous cell growth and malignant transformation of lymphoid cells showing constitutive activation of the JAK-STAT pathway. Freshly isolated murine T cells do not respond to IL-9, but IL-9-dependent cell lines can be observed after long term in vitro culture. This acquisition of IL-9 responsiveness is associated with a transformed phenotype (Uyttenhove et al., 1991) . Interestingly, cytokine-independent cells with a constitutive STAT3 and STAT5 activation can sporadically arise from these IL-9-dependent T-cell clones (Renauld et al., 1995) .
Another model linking IL-9 responsiveness and in vitro transformation stemmed from the study of factordependent Ba/F3 cells transfected with a defective IL-9 receptor (Demoulin et al., 2000) . Ba/F3 is a cell line derived by culturing Balb/c bone marrow B-cell progenitors in the presence of IL-3 (Palacios and Steinmetz, 1985) . Although these cells can grow without limitation in the presence of IL-3, they usually never generate cytokine-independent subpopulations. When Ba/F3 cells were transfected with an IL-9-receptor mutant that lacks the STAT-binding site (tyr116phe), IL-9 almost completely failed to induce STAT activation and proliferation (Demoulin et al., 1996) . However, a small number of cells managed to survive and even proliferated, and IL-9-dependent cell lines could be derived. In contrast to parental cells, those IL-9-selected cells progressed to cytokine-independent tumorigenic clones at low but significant frequencies. Again, these cytokine-independent cells showed a constitutive activation of STAT factors and particularly of STAT5. Those cells, in contrast to the parental cells, were highly tumorigenic when injected in mice (Demoulin et al., 2000) . To better understand mechanisms leading to spontaneous tumorigenesis harboring constitutive STAT activation, we studied genes expressed in transformed Ba/ F3 cells to identify potential molecular mechanisms involved in this model. Our results show that overexpression of JAK kinases can be one of the steps leading to constitutive STAT activation and cytokineindependent growth.
Results

JAK1 is overexpressed in Ba/F3-Phe116-derived autonomous cells
Ba/F3 cells transfected with a mutated hIL-9R (Ba/F3-Phe116), defective in STAT recruitment and activation, poorly respond to IL-9. However, after selection with this factor, we obtained a cell line, designated Ba/F3-Phe116/9, which proliferated well in IL-9. After cytokine withdrawal, those cells, in contrast to the parental cells, gave rise to autonomous Ba/F3 cell lines, which were highly tumorigenic in vivo and were named Ba/F3-A4 or -A6 (Demoulin et al., 2000) . This selection process is schematically represented in Figure 1a . To dissect the mechanisms involved in this cellular transformation, we compared, using cDNA microarrays, the genes expressed in one of these lines, Ba/F3-A6, to the genes expressed in another autonomous Ba/F3 cell line obtained independently by transfection with an oncogenic mutant of M-Ras (Louahed et al., 1999) . Microarray analysis data indicated a 6.8 upregulation of JAK1 in Ba/F3-A6 as compared to Ba/F3-M-Ras. To confirm this overexpression at the protein level, we performed a western blot with an anti-JAK1 antibody. As shown in Figure 1b , JAK1 was overexpressed in Ba/F3-A6 as compared to the parental Ba/F3-Phe116 cell line, and was also overexpressed in another autonomous cell line, Ba/F3-A4. The same overexpression was found in the Ba/F3-Phe116/9 cell line, showing that JAK1 upregulation was a genetic event associated with the first step of selection, namely the selection of IL-9-responsive Ba/F3-Phe116 cells.
Ectopic JAK1 overexpression increases sensitivity to IL-9 To test if JAK1 overexpression could explain the growth advantage in response to IL-9, we stably transfected Ba/ F3-Phe116 cells with a construction encoding the wildtype murine JAK1. JAK1 level was increased 5-to 10-fold in bulk transfectants as compared to wild-type Ba/F3 (western blot, data not shown). This level was similar to the level found in Ba/F3-Phe116/9 and autonomous clones. We stimulated those cells with increasing concentrations of IL-9 and measured proliferation after 2 days. As shown in Figure 2 , while Ba/F3-Phe116 cells poorly responded to IL-9, JAK1 overexpression dramatically increased the responsiveness to this cytokine. Thus, JAK1 overexpression can explain the better response of Ba/F3 cells were transfected with a defective hIL-9R in which Tyr116 was mutated in Phe (Ba/F3-Phe116). Culture in IL-9 led to the selection of a few cells able to proliferate in response to this cytokine (Ba/F3-Phe116/9). These cells could give rise to autonomous cell lines highly tumorigenic in vivo (Ba/F3-A4, Ba/F3-A6), while parental cells were not. (b) JAK1 expression was assessed in these different cell lines by western blot, with a specific anti-JAK1 antibody. As a control, the membrane was reprobed with an antiactin antibody.
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Ba/F3-Phe116/9 cells to IL-9, and was likely the key genetic event associated with the first step of selection. We next tested if the growth advantage resulting from JAK1 overexpression was restricted to the mutated form of the IL-9 receptor, or could also be observed in Ba/F3 cells expressing the wild-type IL-9R (Ba/F3-h9R). As shown in Figure 3 , JAK1 overexpression in Ba/F3-h9R increased about 100 Â the sensitivity to IL-9, while the maximal response appeared slightly decreased. This effect was specific for IL-9, since the response to IL-3, for which JAK2 mediates the signal, was not modified (data not shown). Taken together, these results show that overexpression of JAK1 increases the sensitivity to IL-9.
JAK1 overexpression induces autonomous Ba/F3 cell growth Ba/F3-Phe116 cells selected in IL-9, and overexpressing JAK1, gave rise to autonomous cell lines after cytokine withdrawal. To see if JAK1 overexpression alone could explain this characteristic, we assessed the rate of autonomous lines after washing Ba/F3-Phe116 cells stably transfected with JAK1 and culturing them without cytokine. As shown in Table 1 , Ba/F3-Phe116 cell clones ectopically overexpressing JAK1 gave rise to a significant number of autonomous cell lines, as compared to the absence of autonomous lines arising from control cells, transfected with an empty vector. The same results were obtained with three clones, and cumulative numbers of autonomous lines are represented in Table 1 . Altogether, 77 autonomous lines were obtained from 150 Â 10 6 JAK1-transfected cells tested, a rate that was comparable to the 35 cell lines obtained from 186 Â 10 6 tested Ba/F3-Phe116/9 cells overexpressing JAK1 (Demoulin et al., 2000) . These observations confirm the hypothesis that both the better response to IL-9 and the generation of autonomous cell lines result from JAK1 overexpression.
To test whether the generation of autonomous cell lines might be dependent on the ectopic overexpression of the IL-9 receptor, we transfected wild-type Ba/F3 cells with JAK1. As shown in Table 1 , JAK1 transfectants gave rise to autonomous cells, demonstrating that the phenomenon was IL-9R-independent.
To overcome the potential bias resulting from the utilization of transfected cell clones, we took advantage of bicistronic retroviral vectors, coding for both CD2 and JAK1, allowing to sort cell populations that overexpressed JAK1 based on CD2 expression. JAK1 expression level was similar to the level obtained in stably transfected clones (data not shown). As shown in Table 2 , the overexpression of JAK1 by this method also gave rise to autonomous cell lines, while retroviral transduction of the gamma chain or of the IL-9 receptor, used as control, gave no autonomous cells.
JAK1-induced autonomous cell transformation is dependent on the kinase and FERM domains
Two domains of JAK1 are necessary for signal transduction. The kinase domain is responsible for the autophosphorylation, and for phosphorylation of the receptor and the STAT factors. The FERM domain was essentially shown to mediate receptor association (Kohlhuber et al., 1997) . To assess if the generation of autonomous Ba/F3-JAK1 cell lines depended on the integrity of those two domains, we took advantage of mutated forms of JAK1. To create a kinase-dead JAK1 (JAK1-KD), a point mutation in the conserved ATPbinding domain was introduced (K907A) that rendered JAK1 inactive (data not shown). A mutation in the FERM domain, Y107A, was shown to abolish the capacity of JAK1 to bind to gp130 (Haan et al., 2001) . As shown in Tables 1 and 2 , Ba/F3 cells overexpressing Overexpression of all JAK family members gives rise to autonomous Ba/F3 cell proliferation We showed that JAK1 overexpression confers a growth advantage and leads to the autonomous transformation of Ba/F3 cells. To check if this observation could be extended to the other JAK family members, we ectopically overexpressed the other JAKs in Ba/F3 cells, using both clones obtained after electroporation (Table 1) and cell populations obtained after retroviral transduction (Table 2) . Overexpression of TYK2 led to the autonomous proliferation of Ba/F3 in both experimental systems, demonstrating that high TYK2 levels can promote the autonomous growth of Ba/F3. For JAK2 and JAK3, we obtained significant numbers of autonomous clones (369 for JAK2 and 28 for JAK3, compared to none in control Ba/F3 cells). For JAK2, the difference between transfected and transduced cells can be explained by a different JAK2 expression level obtained with the two methods. As assessed by quantitative PCR, the transfected clones expressed from 11 to 49 times the level of JAK2 obtained for control cells, while transduced lines expressed from 7 to 9 times the endogenous level (data not shown). Nevertheless, these results indicate that overexpression of all JAK members could lead to the autonomous transformation of Ba/F3 cells.
Activated signaling pathways in autonomous clones
For Ba/F3-Phe116/9 cells, which were selected for growth in the presence of IL-9, progression toward cytokine-independent tumorigenic clones was associated with a strong constitutive activation of STAT5 (Demoulin et al., 2000) . We therefore examined if autonomous cell lines obtained after ectopic JAK1 overexpression shared such a constitutive STAT5 activation. As shown in Figure 4 , JAK1 overexpression by itself did not induce STAT5 phosphorylation, but JAK1-overexpressing autonomous cells (Ba/F3-JAK1A) showed a constitutive STAT5 activation, similar to the Ba/F3-A4 line. STAT3, in contrast, was not constitutively activated. We next tested the other signaling pathways activated by IL-3 in Ba/F3. Cytokine-independent growth was associated with a constitutive activation of Erk1-2 and Akt, mimicking to some extent the activation induced by IL-3. These results were reproduced on more than five JAK1 autonomous cell lines tested (data not shown), demonstrating that cytokine-independent progression after JAK1 overexpression is associated with the constitutive activation of the STAT5, MAP kinase and PI3kinase-PKB pathways.
We next analysed the activation of those pathways in autonomous Ba/F3 cells obtained after overexpression of the other JAK family members. As shown in Figure 5 by FACS analysis of cells labeled with anti-phospho-STAT and -Erk antibodies, all autonomous cell lines showed a constitutive activation of STAT5 and Erk1/2. This was confirmed by western blot, as for the constitutive activation of Akt in all autonomous cell lines (data not shown). STAT3 constitutive phosphorylation varied depending on the overexpressed JAK. Phosphorylated STAT3 was reproducibly observed in autonomous clones overexpressing TYK2. STAT3 was also weakly activated in autonomous clones obtained after JAK2 overexpression but not JAK1 or JAK3 overexpression (five autonomous clones tested for each JAK family member). Interestingly, autonomous Ba/F3 cells obtained by the overexpression of a constitutively phosphorylated fusion protein composed of STAT5, the transactivation domain of VP16 and the kinase domain of JAK2 (Demoulin et al., 2000) showed no significant Erk1-2 phosphorylation. Levine et al., 2005) . However, numerous malignancies remain where the origin of constitutive STAT activation is not explained. Our observations point to a possible role of dysregulated activation of overexpressed non-mutated JAK kinases in constitutive STAT activation. In human disease, this hypothesis is difficult to demonstrate compared to a specific and recurrent mutation. Nevertheless, JAK2 overexpression was described in primary mediastinal large B-cell lymphoma and might explain the constitutive STAT6 activation (Guiter et al., 2004) . Moreover, amplification of the JAK2 gene was observed in Hodgkin's lymphoma (Joos et al., 2000 (Joos et al., , 2003 , were STAT3 and STAT5 are often phosphorylated (Kube et al., 2001; Cochet et al., 2006) , and in some cases of acute myeloid leukemia (Rucker et al., 2006) . Overexpression of JAKs is not sufficient to fully transform BaF3 cells, but a significant number of JAKoverexpressing cells can progress toward this stage, which can never be reached spontaneously by parental cells. This contrasts with the mutated JAK2 V617F, for which a majority of transfected BaF3 cells progress to cytokine-independent growth (James et al., 2005; Lu et al., 2005) . In our system, autonomous transformation remains a rare event, which became detectable only when JAK-overexpressing cells were selected and expanded from the bulk parental Ba/F3 population. As a consequence, it is likely that progression to growth -factor independence after an isolated genetic event causing the overexpression of a JAK in a single cell in vivo would require that JAK-overexpressing cells have a selective advantage versus normal cells. Interestingly, as for JAK2 V617F and the response to EPO (James et al., 2005) , we show that JAK overexpression increases the responsiveness to cytokines, at least for IL-9. So, in vivo, JAK overexpression could provide a growth advantage and favor the expansion of JAK-overexpressing cells in the presence of limiting cytokine concentrations. After this first step of selection, progression to a cytokine-independent stage could occur as the result of a second genetic hit. A typical example of such in vivo progression is multiple myeloma. In this disease and in murine myeloma models, proliferation of malignant cells is initially IL-6-dependent. After cytokine withdrawal, like after the administration of IL-6-blocking antibodies, the growth of myeloma cells is decreased, but invariably some IL-6-independent clones arise and proliferate (Trikha et al., 2003) . STAT3, the STAT factor activated by IL-6, was constitutively activated in such autonomous myeloma cells (Rawat et al., 2000) . Whether JAK overexpression is involved in this pathology is an important question that needs further investigation.
The mechanisms involved in the increased cytokine responsiveness could include increased receptor cellsurface expression upon JAK overexpression. This was demonstrated for JAK2 and Erythropoietin, as well as for JAK1 and Oncostatin M. JAK overexpression was associated with a better transport of the receptor to the cell surface (Huang et al., 2001; Radtke et al., 2002) . For the Interferon receptor I, TYK2 was reported to increase cell-surface expression by inhibiting the endocytosis of the receptor (Ragimbeau et al., 2003) . However, the increased cytokine sensitivity could also be explained by other mechanisms. This was illustrated by studies of fusion proteins composed of dimeric-coiled coil and the cytosolic part of the EPO receptor, which allow to identify active and inactive conformation of the receptor dimer. Overexpression of JAK2 allowed the activation of cell signaling with constructs in suboptimal conformation (Seubert et al., 2003) . Higher efficiency of signal transduction due to higher concentration of JAK molecules could also increase cytokine responsiveness.
The way JAK kinases autonomously activate signaling pathways remains elusive. The low level of autonomous lines arising from Ba/F3 cells transfected with JAK1-KD and the high toxicity of the JAK inhibitor on autonomous JAK-overexpressing cells indicate that JAK kinase activity is required for the phenomenon. Absence of autonomous lines arising from cells transfected with a FERM domain-mutated JAK1 suggests that JAKs need to associate to a receptor to mediate constitutive activation of the JAK-STAT pathway. However, the FERM domain was also described as necessary to maintain the integrity of the kinase domain (Zhou et al., 2001) . The requirement of receptor binding is therefore not formally demonstrated by this experiment. Moreover, autonomous progression was comparable in Ba/F3 cells overexpressing JAK1 transfected or not with the IL-9 receptor, which binds JAK1. To our knowledge, with the exception of interferon receptors, there are no JAK1-binding receptors expressed at the surface of Ba/F3 cells, but the presence of such receptors cannot be excluded. So, the need for receptor binding for JAK1 autonomous activity remains possible. The same question stands for JAK2 V617F. Lodish and colleagues demonstrated that transformation of Ba/F3 by the mutant JAK occurred only if an homodimeric type I receptor was co-expressed (Lu et al., 2005) , while for others this was not a prerequisite (James et al., 2005) . Whether constitutively active JAK kinases are free in the cytoplasm or need receptor binding to be active need further attention.
Whatever the mechanism responsible for its constitutive activation, STAT5 is likely responsible for the autonomous growth of Ba/F3 cells, since ectopic expression of constitutively activated STAT5 variants was sufficient for Ba/F3 growth (Demoulin et al., 2000) . However, in all autonomous clones tested, STAT5 activation was associated with constitutive activation of Erk1-2 and AKT, like for JAK2 V617F expressing autonomous Ba/F3 . STAT5, Erk1-2 and Akt are typically activated by IL-3. Inappropriate JAK activation could directly activate regulators of the MAP kinase and the PI3 kinase pathways, like IRS or SHP2. An alternative explanation is that phosphorylation of unknown receptors by active JAKs could mimic cytokine-induced signaling pathways. It is for instance possible that JAK1, in excess, phosphorylate the IL-3 receptor to induce an IL-3-signaling pathway. Another striking observation is the constitutive activation of STAT3, which was observed in all TYK2-overexpressing autonomous clones, sometimes in the JAK2-and never in the JAK1-or JAK3-overexpressing autonomous clones. This could represent unforeseen specificity of the different JAKs, or could reflect the binding to different receptors to induce constitutive activation of the signal. Nevertheless, overexpression of non-mutated JAK or expression of JAK2 V617F (James et al., 2005 ) is in itself not sufficient to lead to autonomous transformation of Ba/F3 cells. We were able to detect an IL-3-autocrine loop in a minority of our autonomous cell lines (data not shown), but it explains less than 10% of the transformation events. For the vast majority of the clones, unknown secondary genetic events are necessary for constitutive activation of the pathway. Such events could include a gain of kinase function allowing JAKconstitutive activation, or the loss of negative regulators of the JAK-STAT pathway. Whether overexpression of JAK kinase could increase the rate of novel activating mutations is speculative. Inactivation of phosphatases such as SHP1 or SHP2, which dephosphorylate JAKs and STATs, might explain JAK deregulation. Other hypotheses include inactivation of negative regulators of the JAK-STAT pathway, such as the SOCS proteins, that were shown to be transcriptionally repressed by hypermethylation in different types of cancer (He et al., 2003; Nagai et al., 2003) . However, we did not detect any decrease in SOCS1, 2, 3 and CISH expression in the five autonomous clones tested (data not shown). We also looked for other potential transcriptional modifications by comparing parental and autonomous cells with Affymetrix microarrays. In the seven autonomous clones tested, there were no differentially expressed genes that could explain the transformation. Nevertheless, other experiments comparing non-autonomous cells overexpressing JAK1 and the derived autonomous cell lines could unravel molecular mechanisms involved in this JAK-STAT constitutive activation, and could be used as a tool to find candidate cofactors involved in the constitutive activation of wild-type or mutated JAKs such as JAK2 V617F.
Materials and methods
Cells and cell culture Pro-B Ba/F3 cells were cultured in Dulbecco's modified Eagle's medium with fetal bovine serum (10%) and IL-3 (100 U ml À1 ), which was produced by transfected CHO cells. The generation of Ba/F3 cells transfected with the hIL-9 receptor (Ba/F3-h9R) or with the mutated IL-9R (Ba/F3-Phe116) was described previously (Demoulin et al., 2000) . Recombinant human IL-9 was produced in the baculovirus system in our laboratory and purified as previously described (Druez et al., 1990) . The frequency of autonomous clones was assessed as previously described (Demoulin et al., 2000) . Transfected or control Ba/F3 cells were grown in the presence of IL-3, and cultured at 1.25 Â 10 5 ml À1 24 h before the experiment. One day later, cells were washed twice with PBS pH 7.4 and 2% FCS, resuspended at 2.5 Â 10 5 ml À1 in culture medium without IL-3, and cultured in microtiter plates 5 Â 10 4 washed cells per well. Plates were checked for proliferating clones during 3 weeks. Clones were subsequently cultured in the same conditions as those described for Ba/F3 cells, but without IL-3.
Plasmid construction, stable DNA transfections and analysis of transfected cells Wild-type and mutated murine JAK1, murine JAK2, human JAK3 and human TYK2 cDNAs were inserted into the pEFbos/puro plasmid (Demoulin et al., 1996) , which contains a resistance gene to puromycin. Ba/F3 cells were transfected by electroporation (300 V, 1200 mF, 74 O) with 50 mg of DNA and selected with puromycin (2.5 mg ml
À1
, Sigma, Bornem, Belgium). Bulk-transfected cultures and clones were used as specified in the experiments. Overexpression of JAKs was controlled by western blot. For retroviral expression, wild-type and mutated mJAK1, mJAK2, hJAK3 and hTYK2 cDNAs were subcloned into the pMX-IRES-CD2 or pMX-IRES-CD4 biscistronic retroviral vector upstream of the IRES (Liu et al., 2000) . Retroviral supernatants were generated by transient transfection of the BOSC packaging cell line with biscistronic vectors encoding the gene of interest and CD2 or CD4 as markers, and used for infection, as described (Liu et al., 2000; Seubert et al., 2003) . Populations of cells expressing CD2 or CD4 above a predetermined level (top 25%) were isolated by FACS sorting.
Proliferation assays A total of 3000 Ba/F3-transfected cells were seeded in 96-well plates, and stimulated by hIL-9 at different concentrations. After 48 h, tritiated thymidine was added to the cultures for 5 h. Cells were then collected on microfilter plates and thymidine incorporation was measured, after addition of liquid scintillant, with a Top Count microplate scintillation counter (CanberraPackard, Meriden, CT, USA).
Viability assay
A total of 30 000 autonomous Ba/F3 cells were seeded in 96-well plates with JAK inhibitor I (Calbiochem, La Jolla, CA, USA; 556 nM), JAK3 inhibitor II, JAK3 inhibitor IV or DMSO alone. After 24 h, cells were incubated for 20 min in propidium iodide (60 mg ml
À1
) at room temperature before FACS analysis with a BD FACSCalibur flow cytometer. Under these conditions dead cells are brightly stained while live cells are not. A total of 5000 cells were counted per sample.
Western blots
Ba/F3 cells were washed and placed for 4 h in medium without IL-3 before stimulation. A total of 10 6 cells were left unstimulated or stimulated with IL-3 (100 U ml À1 ) for 15 min, lysed in 250 ml of Laemmli buffer (BioRad, Hercules, CA, USA) and boiled for 3 min before loading 25 ml on 8% pre-cast sodium dodecyl sulfate-PAGE polyacrylamide gels (Invitrogen, Merelbeke, Belgium) and electrophoretical transfer to nitrocellulose membranes (Hybond-C; Amersham, Buckingham, England). Membranes were then blocked in 5% non-fat dry milk, washed and probed using antibodies specific for JAK1, JAK3 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), JAK2 (Upstate Biotechnology, Lake Placid, NY, USA), TYK2 (Biosource, Camarillo, CA, USA) or phosphorylated STAT3-Y705, STAT5-Y694, AKT-S473, ERK1-2-T202/ Y204 (Cell Signaling, Beverly, MA, USA). Blots were reprobed with anti-b-actin antibodies (Sigma, Bornem Belgium), anti-STAT3 or anti-STAT5 monoclonal antibodies (Transduction Laboratories, Lexington, KY, USA), as a control. A SuperSignal West Pico detection kit (Pierce, Rockford, IL, USA) was used for detection.
FACS analysis
Ba/F3 transfectants were cultured in the presence of IL-3, washed and starved for 4 h. A total of 2 Â 10 5 cells were left unstimulated or stimulated with IL-3 (100 U ml À1 ) for 15 min at 37 1C. Cells were fixed in 2% paraformaldehyde in PBS 10 min at 37 1C and then permeabilized in methanol 90%, 30 min on ice. Cells were washed twice with Hank's medium JAK overexpression promotes cell transformation L Knoops et al. and stained with anti-phosphorylated STAT3-Y705, STAT5-Y694 and ERK1-2-T202/Y204 (BD Pharmingen, San Jose, CA, USA). Cells were analysed on a BD FACSCalibur flow cytometer.
Microarray
Total RNA was extracted from autonomous growing Ba/F3-A6 (Demoulin et al., 2000) and Ba/F3-M-Ras 71K (Louahed et al., 1999) , using the Trizol method as recommended by the manufacturer (Life Technologies, Gent, Belgium). The RNA quality was checked by agarose gel electrophoresis. Total RNA (50 mg) was labeled in reverse transcription reactions (Superscript II kit, Invitrogen) with dCTP-Cy5 for one Ba/F3 cell line and dCTP-Cy3 for the other (Amersham, Buckinghamshire, UK). In every second replicate experiment, the fluorescent deoxynucleotides were swapped. cDNA probes were purified with AutoSeq G-50 columns (Amersham, Buckinghamshire, UK) following the manufacturer's instructions. cDNA labeled with Cy3 and Cy5 were mixed per pair, precipitated and resuspended in hybridization buffer (5 Â SSC, 6 Â Denhardt's solution, 60 mM Tri-HCl pH7.6, 0.12% sarkosyl, 48% formamide). Hybridization to cDNA microarray chips (mver1.1.1) from the Sanger Institute/LICR/CRUK consortium was carried at 47 1C for 16 h. These arrays contained about 15 000 cDNA, with up to 50% derived from novel genes. Hybridizations were done in quadruplicate for each condition. After washing, in 2 Â SSC, 0.1 Â SSC and 0.1% sodium dodecyl sulfate, and finally in 0.1 Â SSC, chips were scanned in a Scannarray Express HT (Packard Bioscience, PerkinElmer, Wellesley, MA, USA) and spot intensities were measured using the QuantArray software (histogram method with background subtraction). Normalization and statistical analysis of the quadruplicate data sets were performed using GeneSpring analysis software (Silicon Genetics). A Lowess non-linear normalization was applied and the median of the ratio distribution for each array was set to 1. For each gene, expression level in Ba/F3-A6 was compared to the level in Ba/ F3-M-Ras 71K cells, used as control (Louahed et al., 1999) .
Reverse transcription-quantitative PCR Total RNA was extracted from 5 Â 10 6 cells using the TriPure isolation reagent (Roche, Basel, Switzerland) according to the manufacturer's instructions. Reverse transcription was performed on 2 mg of total RNA with an oligo-(dT) primer (Roche) and M-MLV RT (Invitrogen). Quantitative PCR was performed using primers sets corresponding to murine JAK2 with qPCR Mastermix for SYBR Green I (Eurogentec, Seraing, Belgium). The sequences of the primers (final concentration: 300 nM) were: 5 0 -CAGCAGCTTGGCAAAGG TAACTTC-3 0 (forward) and 5 0 -TCAGTGCTGTGCTGGAG TTTCTTC-3 0 (reverse). Samples were first heated 2 min at 50 1C then 10 min at 95 1C. cDNA was amplified as follows: 40 cycles of a two-step PCR program at 95 1C for 15 s and 60 1C for 1 min. Melting point analysis was conducted by heating the amplicon from 60 to 95 1C. For b-actin, similar cycling conditions were used with the addition of an internal TaqMan oligonucleotide probe. Primers for b-actin were as follows: 5 0 -TCCTGAGCGCAAGTACTCTGT-3 0 (forward), 5 0 -CTGA TCCACATCTGCTGGAAG-3 0 (reverse) and 5 0 -ATCGGTGG CTCCATCCTGGC-3 0 (Taqman probe).
